Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
C.CentenoM
Here's what each component does, why they're paired, and what to expect
M., Hay, D
& Peschard, O
A Multi-Center, Open-Label, Phase I Study of Single Agent RG7112: A First in Class p53-MDM2 Antagonist, in Patients with Relapsed/Refractory Acute Myeloid and Lymphoid Leukemias (AML/ALL) and Refractory Chronic Lymphocitic Leukemia/Small Cell Lymphocytic Lymphomas (CLL/SCLL)
US$ 22.10
US$ 27.85
US$ 21.18
US$ 23.03
US$ 29.62
US$ 28.03
US$ 23.59
US$ 27.02
US$ 22.12
US$ 26.13
US$ 20.44
